West Omaha Imaging — Omaha, Nebraska

West Omaha Imaging is a clinical research site located in Omaha, Nebraska, United States 68130.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

West Omaha Imaging has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: HER2-positive Breast Cancer.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for West Omaha Imaging?

West Omaha Imaging has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has West Omaha Imaging conducted?

West Omaha Imaging has 1 clinical trials on record, with 1 currently active. Their work covers HER2-positive Breast Cancer.

Is West Omaha Imaging accredited by Crixeo Health?

West Omaha Imaging has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about West Omaha Imaging?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.